PHEX and metabolic dysfunction-associated steatotic liver disease: The liver fibrosis marker HYP content was significantly enhanced in liver tissues of the NAFLD rats, whereas SSJZF treatment could resist the elevated HYP content in liver tissues of the NAFLD rats (Figure 2(C)).